AMGEN INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 55223
 
  
 
C07K PEPTIDES 3735
 
  
 
C07D HETEROCYCLIC COMPOUNDS 22829
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 17439
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 7929
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4654
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 45161
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 4114
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 32122
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 32106

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0021,508 ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMPFeb 10, 16Jan 25, 18[A61M]
2018/0021,521 DRUG DELIVERY DEVICE WITH A ROTATABLE DRIVE MECHANISMJul 17, 17Jan 25, 18[A61M]
2018/0002,417 Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac DiseaseJun 14, 17Jan 04, 18[A61K, C07K]
2018/0002,733 METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINSJul 17, 17Jan 04, 18[C12P, C12N, C07K]
2017/0369,837 FEED MEDIAAug 08, 17Dec 28, 17[C12N]
2017/0360,857 Stable Frozen Virus FormulationDec 15, 15Dec 21, 17[A61K, C12N]
2017/0355,741 Production Of Glycoproteins Using ManganeseAug 22, 17Dec 14, 17[C12P, C12N, C07K]
2017/0306,033 BI-SPECIFIC ANTI-CGRP RECEPTOR/PAC1 RECEPTOR ANTIGEN BINDING PROTEINS AND USES THEREOFSep 15, 15Oct 26, 17[C07K]
2017/0275,365 ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODYNov 09, 16Sep 28, 17[C07K]
2017/0247,476 PROTEASE-ACTIVATABLE BISPECIFIC PROTEINSSep 24, 15Aug 31, 17[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920114 Antibody formulationsMar 16, 17Mar 20, 18[A61K, C07K]
9920121 Antibodies targeting CDH19 for melanomaJan 27, 14Mar 20, 18[A61K, C07K]
9920134 Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)Jun 30, 11Mar 20, 18[A61K, C12N, C07K]
9922429 Methods and apparati for nondestructive detection of undissolved particles in a fluidJun 27, 16Mar 20, 18[G06T, G01N]
D813380 On-body injectorAug 05, 16Mar 20, 18[2402]
9913900 Method of treating alvelor bone loss through the use of anti-sclerostin antibodiesApr 21, 17Mar 13, 18[A61K, C07K]
9914779 Administration of alpha4beta7 hetero-dimer-specific antibodyNov 21, 12Mar 13, 18[A61K, G01N, C07K]
9895308 Heterocyclic compounds and their usesMar 14, 14Feb 20, 18[A61K]
9892523 Methods and apparati for nondestructive detection of undissolved particles in a fluidJun 27, 16Feb 13, 18[G06T, G01N]
9879072 DKK1 antibodies and methods of useOct 27, 11Jan 30, 18[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0267,673 CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USEAbandonedNov 17, 16Sep 21, 17[C07D]
2017/0144,971 Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAbandonedJan 23, 17May 25, 17[C07D]
2017/0137,526 USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOFAbandonedJan 24, 17May 18, 17[C07K]
2016/0287,570 PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITORAbandonedJun 07, 16Oct 06, 16[A61K]
2016/0280,703 Heteroaryloxycarbocyclyl Compounds as PDE 10 InhibitorsAbandonedDec 22, 14Sep 29, 16[C07D]
2016/0244,497 FGF21 MUTANTS AND USES THEREOFAbandonedJan 27, 16Aug 25, 16[A61K, C07K]
2016/0237,147 Human Anti-NGF Neutralizing Antibodies As Selective NGF Pathway InhibitorsAbandonedJan 19, 16Aug 18, 16[C07K]
2016/0222,075 PRODUCTION OF GLYCOPROTEINS USING MANGANESEAbandonedJan 22, 16Aug 04, 16[C07K]
9382309 Variant activin IIB receptorWithdrawnMar 11, 14Jul 05, 16[C07K]
2016/0152,683 NOVEL ACTIVIN RECEPTOR AND USES THEREOFAbandonedFeb 03, 16Jun 02, 16[C07K]
2016/0137,708 IL-1 FAMILY VARIANTSAbandonedJan 22, 16May 19, 16[C12Q, C07K]
2016/0060,337 METHODS FOR TREATING PSORIASIS USING AN ANTI-IL-23 ANTIBODYAbandonedFeb 25, 14Mar 03, 16[C07K]
2016/0060,591 FEED MEDIAAbandonedNov 10, 15Mar 03, 16[C12N]
2016/0046,709 METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITORAbandonedSep 22, 15Feb 18, 16[A61K, C12Q, C07K]
2016/0039,945 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9AbandonedMar 12, 14Feb 11, 16[A61K, G01N, C07K]
2016/0031,983 METHODS FOR TREATING CROHN'S DISEASE USING AN ANTI-IL23 ANTIBODYAbandonedFeb 25, 14Feb 04, 16[C07K]
2016/0031,997 METHODS AND COMPOSITIONS RELATING TO ANTI-CCR7 ANTIGEN BINDING PROTEINSAbandonedMar 14, 14Feb 04, 16[C07K]
2016/0032,014 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9AbandonedMar 14, 14Feb 04, 16[C07K]
2015/0353,542 METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTUREAbandonedDec 11, 13Dec 10, 15[C07D]
2015/0322,144 Antibodies that Bind Myostatin, Compositions and MethodsAbandonedMar 19, 15Nov 12, 15[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.